A Study to Evaluate Catheter Ablation Outcomes in Athletes with Atrial Fibrillation


About this study

The purpose of this study is to analyze the effectiveness and outcomes of atrial fibrillation ablation in athletes.


Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:  

  • Patients 18 years of age or older.
  • Patient who underwent atrial fibrillation ablation with a history of endurance sport participation.

Exclusion Criteria: 

  • Patient is under 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Luis Scott, M.D.

Contact us for the latest status

Contact information:

Luis Scott M.D.


More information


Publications are currently not available